Skip to main content

2nd Utah Amyloidosis Symposium

Friday- May 17, 2019 ~ 8:00am - 4:00pm
Spencer F. & Cleone P. Eccles Health Sciences Education Building University of Utah, Salt Lake City

Amyloidosis Conference Group Photo

On behalf of the Organizing Committee, it was our great pleasure to host the 2nd Utah Amyloidosis Symposium in Salt Lake City, UT. The 2019 symposium was held on Friday, May 17, 2019 in the University of Utah Spencer F. & Cleone P. Eccles Health Sciences Education Building (HSEB) - Alumni Hall, 26 South 2000 East, Salt Lake City, UT 84112.

The objective of the Utah Amyloidosis Symposium was to develop a forum that would catalyze, advocate, and provide education that promotes change, development and improvement for the early diagnosis and management of amyloidosis.

This year's symposium ran from 8:00am - 4:30pm with a reception to follow at the University of Utah Guest House from 5-9pm.  Registration options for each event can be found below.


This event has passed, registration is now CLOSED. 

2019 Keynote Speakers:

Giovanni Palladini, MD, PhD
Light Chain Amyloidosis Focus

Giovanni Palladini, MD, PhD, headshot


  • Acting Director, Amyloidosis Research and Treatment Center, Foundation “Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo” and Department of Molecular Medicine, University of Pavia, Pavia, Italy.


Vaishali Sanchorawala, MD
The Role of Stem Cell Transplant Amidst Emerging Therapies in the Treatment in AL Amyloidosis

Vaishali Sanchorawala, MD, headshot


  • Director, Autologous Stem Cell Transplant Program; Director, Amyloidosis Center
    Boston University School of Medicine
    Boston, MA


Mathew Maurer, MD
The Changing Landscape in ATTR Amyloidosis

Mathew Maurer, MD, headshot
  • Medical director of The HCM Center
    New York-Presbyterian Hospital/Columbia University Medical Center
    New York, NY


Sami L. Khella, MD
The Impact of Gene Silencers in Neuropathy and Quality of Life in Patients with Familial Amyloidosis

Neuropathy Scales for Clinical Practice vs Trials

Sami L. Khella, MD, PhD
  • Chief, Department of Neurology, Penn Presbyterian Medical Center
    University of Pennsylvania School of Medicine

    Philadelphia, PA


Isabelle Lousada
Quality of Life in Amyloidosis

Isabelle Lousada, headshot
  • CEO and President, Amyloidosis Research Consortium
    Boston, MA


Grand Rounds: Emerging Therapies for Amyloidosis Cardiomyopathy

Grand Rounds: Amyloidosis: A rapidly moving field